Skip to content

Trial Summary

An Australian, non-interventional registry to evaluate clinical outcomes and bevacizumab use in metastatic colorectal cancer from routine clinical practise.



ACTRN/NCT /ethics:


Scientific title:

Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer

Sponsor / Cooperative group:

Royal Marsden NHS Foundation Trust

Trial & Patient Characteristics

Cancer TypeBowel and colon
Trial TypeEarly detection, diagnosis, prognosis
PhaseAll phases
Age Range18 years and older
Tumour Stream Colorectal
Cancer StageMetastatic or Widespread
Anticipated Start DateN/A
Anticipated End DateN/A

Participating Hospitals

HospitalMt Gambier General Hospital
Clinical Trial CoordinatorJane Fuller
Principal InvestigatorDr Arwa Abdelomogod
Recruitment StatusRecruiting